ライフサイエンスコーパス: sitting position

1 d, in the same order used when they were the sitting position.

2 nilateral and bilateral isometric force in a sitting position.

3 Second, all measures were repeated in the sitting position.

4 was higher in the reclining compared to the sitting position.

5 daptation, 5 scans were then obtained in the sitting position.

6 tected when experimental subjects are in the sitting position.

7 vivo to be greater in the standing than the sitting position.

8 ot vary significantly between the supine and sitting positions.

9 /- 1.01 vs. 1.90 +/- 1.74, P = 0.010) or the sitting position (0.75 +/- 0.93 vs. 1.38 +/- 1.60, P = 0

10 ined using measurements from both supine and sitting positions, also yielding the highest rate of cor

11 Twenty-two did the first testing in the sitting position and 28 standing.

12 Mean TLCPD was 3.1+/-6.0 mmHg in the sitting position and 3.1+/-7.0 mmHg in the supine positi

13 was 3.8 +/- 0.6 mm Hg (mean +/- SEM) in the sitting position and 3.4 +/- 0.6 mm Hg in the supine pos

14 Combining sitting position and applied positive end-expiratory pre

15 One patient who underwent DBT VAB in the sitting position and one patient who underwent PS VAB de

16 Measurements were taken in both the sitting position and the supine position during the ligh

17 men during quiet respiration in the erect or sitting position and while exercising.

18 RO tonometry correlates well with GAT in the sitting position, and with the Tono-Pen in both the sitt

19 ldmann applanation tonometry recorded in the sitting position at 9 am, 10 am, 11 am, noon, 2 pm, 3 pm

20 e performed and the cornea was marked in the sitting position at the slit lamp.

21 was obtained by tonometry, in the supine and sitting positions before and after 4-12 months of spacef

22 was obtained by tonometry, in the supine and sitting positions before and after 4-12 months of spacef

23 art-to-detector distances than the supine or sitting positions (both P < 0.001); lower cardiac motion

24 OP) was measured with the participant in the sitting position by using a pneumatonometer.

25 gles of the eyes were measured in supine and sitting positions by ultrasound biomicroscopy (UBM) with

26 obese patients under mechanical ventilation, sitting position constantly and significantly relieved e

27 using a pneumotonometer every 2 hours in the sitting position during the 16-hour diurnal period and i

28 in the supine position and 5 minutes in the sitting position during the 16-hour diurnal/wake period

29 measurements were taken with subjects in the sitting position during the light-wake period and supine

30 collected from subjects while resting in the sitting position for one hour.

31 raocular pressure (IOP) were measured in the sitting position, for calculation of OPP.

32 extended diurnal IOP profiles measured in a sitting position had been collected over a period of 114

33 eleration to the time at which subjects in a sitting position indicated perceiving a change in veloci

34 In the sitting position, IOP was measured in neutral neck posit

35 urve at baseline, 6 and 12 weeks (supine and sitting position IOPs were recorded at 8 p.m., midnight,

36 Sitting position not only reverses partially or complete

37 ic loading stress performed in an upright or sitting position or under axial loading by using a compr

38 ation, with the patient in a head-up tilt or sitting position the decrease in mitral E velocity with

39 With the kitten in a Sitting position, these included stereotypical Head and

40 verage VA demand at the furthest and nearest sitting position to the board was 0.21 +/- 0.23 and 0.65

41 nts performed conventional spirometry in the sitting position using room air, in the supine position

42 vital capacity (FVC) in the standing versus sitting position (Wilcoxen test, p < or = 0.05).

43 ng in the supine position (n = 40) or in the sitting position with the back rearward at 30 degrees fr

44 al arm weakness were tested in a standing or sitting position with the elbows flexed at 30 degrees .